NL8401317A - Nieuwe acylaminofenolderivaten. - Google Patents

Nieuwe acylaminofenolderivaten. Download PDF

Info

Publication number
NL8401317A
NL8401317A NL8401317A NL8401317A NL8401317A NL 8401317 A NL8401317 A NL 8401317A NL 8401317 A NL8401317 A NL 8401317A NL 8401317 A NL8401317 A NL 8401317A NL 8401317 A NL8401317 A NL 8401317A
Authority
NL
Netherlands
Prior art keywords
compound
new
formula
thiazolidine
oxo
Prior art date
Application number
NL8401317A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8401317A publication Critical patent/NL8401317A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL8401317A 1983-05-04 1984-04-24 Nieuwe acylaminofenolderivaten. NL8401317A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH242383 1983-05-04
CH2423/83A CH654302A5 (de) 1983-05-04 1983-05-04 Acylaminophenolderivate, ihre herstellung und arzneimittel, welche sie enthalten.

Publications (1)

Publication Number Publication Date
NL8401317A true NL8401317A (nl) 1984-12-03

Family

ID=4233464

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401317A NL8401317A (nl) 1983-05-04 1984-04-24 Nieuwe acylaminofenolderivaten.

Country Status (24)

Country Link
US (1) US4567192A (it)
JP (1) JPS59206371A (it)
AT (1) AT387015B (it)
AU (1) AU573215B2 (it)
BE (1) BE899526A (it)
CA (1) CA1233471A (it)
CH (1) CH654302A5 (it)
DE (1) DE3415666A1 (it)
DK (1) DK218984A (it)
ES (1) ES8505665A1 (it)
FI (1) FI841731A (it)
FR (1) FR2545489B1 (it)
GB (1) GB2139225B (it)
GR (1) GR81496B (it)
HU (1) HU189866B (it)
IL (1) IL71723A (it)
IT (1) IT1181803B (it)
LU (1) LU85348A1 (it)
NL (1) NL8401317A (it)
NZ (1) NZ208027A (it)
PH (1) PH20351A (it)
PT (1) PT78526B (it)
SE (1) SE8402361L (it)
ZA (1) ZA843379B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594826B1 (fr) * 1986-02-26 1992-08-07 Panmedica Sa Nouveaux n-acyl derives d'esters amino-4 phenyle de l'acide oxo-2 pyrrolidine carboxylique 5, preparation et medicaments les contenant
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
CN102149412A (zh) * 2008-05-20 2011-08-10 纽罗吉斯克斯公司 肝脏保护剂对乙酰氨基酚协同前药

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
US4438124A (en) * 1981-02-11 1984-03-20 Cornell Research Foundation, Inc. Cysteine delivery system

Also Published As

Publication number Publication date
SE8402361D0 (sv) 1984-05-02
PT78526A (en) 1984-06-01
BE899526A (fr) 1984-10-29
AT387015B (de) 1988-11-25
CH654302A5 (de) 1986-02-14
ZA843379B (en) 1985-12-24
HU189866B (en) 1986-08-28
HUT37133A (en) 1985-11-28
FR2545489B1 (fr) 1987-01-23
AU573215B2 (en) 1988-06-02
PH20351A (en) 1986-12-04
ES532142A0 (es) 1985-06-01
FI841731A (fi) 1984-11-05
IT1181803B (it) 1987-09-30
DE3415666A1 (de) 1984-11-08
SE8402361L (sv) 1984-11-05
IT8448135A0 (it) 1984-05-04
AU2759684A (en) 1984-11-08
DK218984A (da) 1984-11-05
GB2139225A (en) 1984-11-07
JPS59206371A (ja) 1984-11-22
CA1233471A (en) 1988-03-01
US4567192A (en) 1986-01-28
FI841731A0 (fi) 1984-05-02
ATA146384A (de) 1988-04-15
GB2139225B (en) 1986-09-10
NZ208027A (en) 1987-06-30
FR2545489A1 (fr) 1984-11-09
IL71723A (en) 1987-10-30
DK218984D0 (da) 1984-05-02
PT78526B (en) 1986-07-14
GR81496B (it) 1984-12-11
IL71723A0 (en) 1984-09-30
LU85348A1 (fr) 1985-03-21
ES8505665A1 (es) 1985-06-01
GB8411012D0 (en) 1984-06-06

Similar Documents

Publication Publication Date Title
CN104230971B (zh) 作为脂肪酰胺水解酶抑制剂的硼酸和酯
JP6989505B2 (ja) Malt1阻害剤およびその使用
CA2994404C (en) Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
JPS62240619A (ja) 制癌剤
JPH02157260A (ja) アミノ安息香酸およびアミノシクロヘキサンカルボン酸化合物並びに医薬組成物
CA2371857C (en) Gardos channel antagonists
AU621041B2 (en) Beta-aminoethyl-substituted compounds and halo- azido- and phthalimido-ethyl-substituted phenyl intermediates
KR20180107261A (ko) Myc 조정제로서의 MAX 결합제 및 그의 용도
EA018127B1 (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
CA2636042A1 (en) Lanthionine-related compounds for the treatment of inflammatory diseases
JP2019512475A (ja) 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒
NL8401317A (nl) Nieuwe acylaminofenolderivaten.
EP0391971A1 (en) IMPROVED TOXICITY CURVES IN CHEMOTHERAPY.
US3210247A (en) Anti-epileptic i-cyclohexyl-z-methyl- aiviino propane salt of phenyl ethyl barbituric acid
US5149688A (en) Methods, compounds, and compositions for immunosuppression
RU2418580C1 (ru) Цинксодержащий антидот отравления этанолом и способ лечения с его использованием
CA3191714A1 (en) Benzylamine derivative, preparation method therefor and use thereof
JPH0262544B2 (it)
CN111094259B (zh) 止痛化合物
EP0094425A1 (en) 2,6-Di (t-butyl) -4- (2'-pyrroyl) phenol and anti-inflammatory compositions.
JPS6320426B2 (it)
JPS6270335A (ja) 2環性アリルエ−テル誘導体、その製法および用途
WO2019103660A1 (en) Method of multiple sclerosis treatment (variants)
JPS591478A (ja) 4,5―ジヒドロキシ―1,3―ジチオラン―2―イリデンマロン酸誘導体
KR890000381B1 (ko) 아실아미노페놀 유도체의 제조방법

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed